Editas Medicine

Editas Medicine is a leading biotechnology company focused on developing CRISPR-based medicines to treat people with serious diseases. It pioneers genome-editing therapies, translating CRISPR research into clinical programs aimed at delivering transformative treatments. The company concentrates on building a pipeline of investigational medicines and collaborating across the biotech ecosystem to advance gene editing from the lab to the clinic. By leveraging precision genome editing, Editas Medicine seeks to expand treatment options for patients with previously intractable conditions.